Which way for drug-mediated immunosuppression?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Germain, 1994, MHC-dependent Antigen Processing and Peptide Presentation: Providing Ligands for T-Lymphocyte Activation, Cell, 76, 287, 10.1016/0092-8674(94)90336-0
Weiss, 1994, Signal Transduction by Lymphocyte-Antigen Receptors, Cell, 76, 263, 10.1016/0092-8674(94)90334-4
Clevers, 1988, The T-cell Receptor/CD3 Complex: A Dynamic Protein Ensemble, Annu Rev Immunol, 6, 629, 10.1146/annurev.iy.06.040188.003213
Shoskes, 1994, Indirect Presentation of MHC Antigens in Transplantation, Immunol Today, 15, 32, 10.1016/0167-5699(94)90023-X
Miceli, 1991, The Role of CD4 and CD8 in T-Cell Activation, Semin Immunol, 3, 133
Suthanthiran, 1990, A Novel Model for Antigen-dependent Activation of Normal Human T-Cells. Transmembrane Signaling by Crosslinkage of the CD3/T Cell Receptor-α/β Complex with the Cluster Determinant 2 Antigen, J Exp Med, 171, 1965, 10.1084/jem.171.6.1965
Brown, 1989, The CD2 Antigen Associates with the T-Cell Antigen Receptor/CD3/Antigen Complex on the Surface of Human T Lymphocytes, Nature, 339, 551, 10.1038/339551a0
Beyers, 1992, Molecular Associations Between the T-lymphocyte Antigen Receptor Complex and the Surface Antigens CD2, CD4, or CD8 and CD5, 89, 2945
Klausner, 1991, T-cell Antigen Receptor Activation Pathways: The Tyrosine Kinase Connection, Cell, 64, 875, 10.1016/0092-8674(91)90310-U
Nishizuka, 1992, Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C, Science, 258, 607, 10.1126/science.1411571
O'Keefe, 1992, FK-506 and CsA-Sensitive Activation of the Interleukin-2 Promoter by Calcineurin, Nature, 357, 692, 10.1038/357692a0
Clipstone, 1992, Identification of Calcineurin as a Key Signalling Enzyme in T-lymphocyte Activation, Nature, 357, 695, 10.1038/357695a0
Liu, 1991, Calcineurin is a Common Target of Cyclophilin-Cyclosporin A and FKBP-FK506 Complexes, Cell, 66, 807, 10.1016/0092-8674(91)90124-H
Fruman, 1992, Calcineurin Phosphatase Activity in T Lymphocytes is Inhibited by FK 506 and Cyclosporin A, 89, 3686
Suthanthiran, 1993, Signaling Features of T Cells: Implications for the Regulation of the Anti-allograft Response, Kidney Int, 44, S3
Dustin, 1989, T-cell Receptor Crosslinking Transiently Stimulates Adhesiveness Through LFA-1, Nature, 341, 619, 10.1038/341619a0
Williams, 1985, The Events of Primary T-cell Activation Can be Staged by Use of Sepharose-bound Anti-T3 [64.1] Monoclonal Antibody and Purified Interleukin-1, J Immunol, 135, 2249
June, 1990, Role of the CD28 Receptor in T-Cell Activation, Immunol Today, 11, 211, 10.1016/0167-5699(90)90085-N
Linsley, 1991, CTLA-4 is a Second Receptor for the B-Cell Activation Antigen B7, J Exp Med, 174, 561, 10.1084/jem.174.3.561
Thompson, 1989, CD28 Activation Pathway Regulates the Production of Multiple T Cell-De rived Lymphokines/Cytokines, 86, 1333
Sigal, 1991, Inhibition of Human T-cell Activation by FK506, Rapamycin and Cyclosporine A, 232, 1
Isobe, 1992, Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1, 255, 1125
Linsley, 1992, Immunosuppression In Vivo by a Soluble Form of the CTLA-4 T-Cell Activation Molecule, Science, 257, 792, 10.1126/science.1496399
Bretcher, 1970, A Theory of Self-Non-self Discrimination: Paralysis and Induction Involve the Recognition of One and Two Determinants on an Antigen, Respectively, Science, 169, 1042, 10.1126/science.169.3950.1042
Schreiber, 1992, Immunophilin-sensitive Protein Phosphatase Activation in Cell Signaling Pathways, Cell, 70, 365, 10.1016/0092-8674(92)90158-9
Roberts, 1993, Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β), Growth Factors, 8, 1, 10.3109/08977199309029129
Li, 1991, Differential Regulation of Transforming Growth Factor β and Interleukin-2 Genes in Human T-Cells: Demonstration by Usage of Novel Competitor DNA Constructs in the Quantitative Polymerase Chain Reaction, J Exp Med, 174, 1259, 10.1084/jem.174.5.1259
Khanna, 1994, Regulation of New DNA Synthesis in Mammalian Cells by Cyclosporine. Demonstration of a Transforming Growth Factor β-Dependent Mechanism of Inhibition of Cell Growth, Transplantation, 57, 577, 10.1097/00007890-199402000-00018
Knudsen, 1987, Glucocorticoids Inhibit Transcription and Post-transcriptional Expression of Interleukin-6, J Immunol, 139, 4129
Zanker, 1990, Evidence That Glucocorticosteroids Block Expression of the Human Interleukin-6 Gene by Accessory Cells, Transplantation, 49, 198, 10.1097/00007890-199001000-00040
Arya, 1984, Dexamethasone Mediated Inhibition of T-Cell Growth Factor and γInterferon Messenger RNA, J Immunol, 133, 273
Almawi, 1991, Abrogation of Glucocorticosteroid-mediated Inhibition of T-cell Proliferation by the Synergistic Action of IL-1, IL-6 and IFN, J Immunol, 146, 3523
Vacca, 1992, Glucocorticoid Receptor-mediated Suppression of the Interleukin-2 Gene Expression Through Impairment of the Cooperativity Between Nuclear Factor of Activated T-cells and AP-1 Enhancer Elements, J Exp Med, 175, 637, 10.1084/jem.175.3.637
Elion, 1967, Biochemistry and Pharmacology of Purine Analogues, 26, 898
Bach, 1986, In The Mode of Action of Immunosuppressive Agents, vol 9, 105
Morris, 1992, Rapamycins: Antifungal, Antitumor, Antiproliferative and Immunosuppressive Macrolides, Transplant Rev, 6, 39, 10.1016/S0955-470X(10)80014-X
Chung, 1992, Rapamycin-FKBP Specifically Blocks Growth-dependent Activation of and Signaling by, the 70 kD S6 Protein Kinases, Cell, 69, 1227, 10.1016/0092-8674(92)90643-Q
Sabatini, 1994, Raft-1: A Mammalian Protein That Binds to FKBP 12 in a Rapamycin-dependent Fashion and is Homologous to Yeast TORS, Cell, 78, 35, 10.1016/0092-8674(94)90570-3
Morris, 1991, Comparison of the Immunosuppressive Effects of Mycophenolic Acid and the Morpholinethal Ester of Mycophenolic Acid (RS-61443) in Recipients of Heart Grafts, 23, 493
Sweeney, 1972, Metabolism and Biochemistry of Mycophenolic Acid, Cancer Res, 32, 1803
Sollinger, 1992, RS-61443-A Phase 1 Clinical Trial and Pilot Rescue Study, Transplantation, 53, 428, 10.1097/00007890-199202010-00031
Turka, 1991, Guanine Ribonucleotide Depletion Inhibits T-cell Activation: Mechanism of Action of the Immunosuppressive Drug Mizoribine, J Clin Invest, 87, 940, 10.1172/JCI115101
Kokado, 1990, Low Dose Ciclosporin, Mizoribine and Prednisone in Renal Transplantation: A New Triple Drug Therapy, Clin Transplant, 4, 191
Takeuchi, 1981, A New Anti-tumor Antibiotic, Spergualin: Isolation and Antitumor Activity, J Antibiot (Tokyo), 34, 1619, 10.7164/antibiotics.34.1619
Umeda, 1985, Synthesis and Antitumor Activity of Spergualin Analogues. I1. Chemical Modification of 7-guanidino-3-hydroxyacyl Moiety, J Antibiot (Tokyo), 38, 886, 10.7164/antibiotics.38.886
Nadler, 1992, Interaction of the Immunosuppressant Deoxyspergualin with a Member of the Hsp70 Family of Heat Shock Proteins, Science, 258, 484, 10.1126/science.1411548
Makowka, 1993, The Development of Brequinar as an Immunosuppressive Drug for Transplantation, Immunol Rev, 136, 51, 10.1111/j.1600-065X.1993.tb00654.x
Allison, 1993, Immunosuppressive and Other Effects of Mycophenolic Acid and an Ester Prodnig, Mycophenolate Mofetil, Immunol Rev, 136, 5, 10.1111/j.1600-065X.1993.tb00652.x
Scheier, 1993, Inhibition of T-Cell Signalling Pathways by Immunophilin Drug Complexes: Are Side Effects Inherent to Immunosuppressive Properties?, 25, 502